Effective October 1, 2011, prior authorization and quantity limit requirements were applied to additional drugs for members enrolled in an IBC prescription drug program.
The purpose of prior authorization is to ensure that drugs are medically necessary and are being used appropriately. Quantity limits are designed to allow a sufficient supply of medication based upon the maximum daily dose and length of therapy approved by the U.S. Food and Drug Administration for a particular drug.
View the most recent updates in Partners in Health UpdateSM.